世界の静脈内(IV)療法及び静脈アクセス市場 2019年

【英語タイトル】Global Intravenous (IV) Therapy and Vein Access Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB03914)・商品コード:QYR20FB03914
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、静脈内(IV)療法及び静脈アクセスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、輸液ポンプ、移植可能ポート、静脈カテーテル、皮下注射針、その他に、用途別には、病院、診療所、その他にセグメント区分し、静脈内(IV)療法及び静脈アクセスの世界市場を分析しました。


・エグゼクティブ・サマリー
・静脈内(IV)療法及び静脈アクセスの世界市場概要
・静脈内(IV)療法及び静脈アクセスの製造コスト構成分析
・静脈内(IV)療法及び静脈アクセスの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・静脈内(IV)療法及び静脈アクセスの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・静脈内(IV)療法及び静脈アクセスのセグメント分析(種類別)
(輸液ポンプ、移植可能ポート、静脈カテーテル、皮下注射針、その他)
・静脈内(IV)療法及び静脈アクセスのセグメント分析(用途別)
(病院、診療所、その他)
・静脈内(IV)療法及び静脈アクセスの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(B. Braun、Baxter International、Becton Dickinson、C. R. Bard、Fresenius Kabi、Hospira(ICU Medical)、Medtronic、Smiths Group、Teleflex)
・静脈内(IV)療法及び静脈アクセスの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous (IV) Therapy and Vein Access market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Therapy and Vein Access volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Therapy and Vein Access market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Therapy and Vein Access in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intravenous (IV) Therapy and Vein Access manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Infusion pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other

Segment by Application
Hospital
Clinics
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Intravenous (IV) Therapy and Vein Access
1.1 Definition of Intravenous (IV) Therapy and Vein Access
1.2 Intravenous (IV) Therapy and Vein Access Segment by Type
1.2.1 Global Intravenous (IV) Therapy and Vein Access Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Infusion pumps
1.2.3 Implantable Ports
1.2.4 Intravenous Catheters
1.2.5 Hypodermic Needles
1.2.6 Other
1.3 Intravenous (IV) Therapy and Vein Access Segment by Applications
1.3.1 Global Intravenous (IV) Therapy and Vein Access Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Intravenous (IV) Therapy and Vein Access Overall Market
1.4.1 Global Intravenous (IV) Therapy and Vein Access Revenue (2014-2025)
1.4.2 Global Intravenous (IV) Therapy and Vein Access Production (2014-2025)
1.4.3 North America Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)
1.4.4 Europe Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)
1.4.5 China Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)
1.4.6 Japan Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)
1.4.7 Southeast Asia Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)
1.4.8 India Intravenous (IV) Therapy and Vein Access Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Therapy and Vein Access
2.3 Manufacturing Process Analysis of Intravenous (IV) Therapy and Vein Access
2.4 Industry Chain Structure of Intravenous (IV) Therapy and Vein Access

3 Development and Manufacturing Plants Analysis of Intravenous (IV) Therapy and Vein Access
3.1 Capacity and Commercial Production Date
3.2 Global Intravenous (IV) Therapy and Vein Access Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Intravenous (IV) Therapy and Vein Access
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Intravenous (IV) Therapy and Vein Access Production and Capacity Analysis
4.2 Intravenous (IV) Therapy and Vein Access Revenue Analysis
4.3 Intravenous (IV) Therapy and Vein Access Price Analysis
4.4 Market Concentration Degree

5 Intravenous (IV) Therapy and Vein Access Regional Market Analysis
5.1 Intravenous (IV) Therapy and Vein Access Production by Regions
5.1.1 Global Intravenous (IV) Therapy and Vein Access Production by Regions
5.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue by Regions
5.2 Intravenous (IV) Therapy and Vein Access Consumption by Regions
5.3 North America Intravenous (IV) Therapy and Vein Access Market Analysis
5.3.1 North America Intravenous (IV) Therapy and Vein Access Production
5.3.2 North America Intravenous (IV) Therapy and Vein Access Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Intravenous (IV) Therapy and Vein Access Import and Export
5.4 Europe Intravenous (IV) Therapy and Vein Access Market Analysis
5.4.1 Europe Intravenous (IV) Therapy and Vein Access Production
5.4.2 Europe Intravenous (IV) Therapy and Vein Access Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Intravenous (IV) Therapy and Vein Access Import and Export
5.5 China Intravenous (IV) Therapy and Vein Access Market Analysis
5.5.1 China Intravenous (IV) Therapy and Vein Access Production
5.5.2 China Intravenous (IV) Therapy and Vein Access Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Intravenous (IV) Therapy and Vein Access Import and Export
5.6 Japan Intravenous (IV) Therapy and Vein Access Market Analysis
5.6.1 Japan Intravenous (IV) Therapy and Vein Access Production
5.6.2 Japan Intravenous (IV) Therapy and Vein Access Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Intravenous (IV) Therapy and Vein Access Import and Export
5.7 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Analysis
5.7.1 Southeast Asia Intravenous (IV) Therapy and Vein Access Production
5.7.2 Southeast Asia Intravenous (IV) Therapy and Vein Access Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Intravenous (IV) Therapy and Vein Access Import and Export
5.8 India Intravenous (IV) Therapy and Vein Access Market Analysis
5.8.1 India Intravenous (IV) Therapy and Vein Access Production
5.8.2 India Intravenous (IV) Therapy and Vein Access Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Intravenous (IV) Therapy and Vein Access Import and Export

6 Intravenous (IV) Therapy and Vein Access Segment Market Analysis (by Type)
6.1 Global Intravenous (IV) Therapy and Vein Access Production by Type
6.2 Global Intravenous (IV) Therapy and Vein Access Revenue by Type
6.3 Intravenous (IV) Therapy and Vein Access Price by Type

7 Intravenous (IV) Therapy and Vein Access Segment Market Analysis (by Application)
7.1 Global Intravenous (IV) Therapy and Vein Access Consumption by Application
7.2 Global Intravenous (IV) Therapy and Vein Access Consumption Market Share by Application (2014-2019)

8 Intravenous (IV) Therapy and Vein Access Major Manufacturers Analysis
8.1 B. Braun
8.1.1 B. Braun Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.1.2 B. Braun Product Introduction, Application and Specification
8.1.3 B. Braun Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Baxter International
8.2.1 Baxter International Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.2.2 Baxter International Product Introduction, Application and Specification
8.2.3 Baxter International Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Becton Dickinson
8.3.1 Becton Dickinson Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.3.2 Becton Dickinson Product Introduction, Application and Specification
8.3.3 Becton Dickinson Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 C. R. Bard
8.4.1 C. R. Bard Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.4.2 C. R. Bard Product Introduction, Application and Specification
8.4.3 C. R. Bard Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Fresenius Kabi
8.5.1 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.5.2 Fresenius Kabi Product Introduction, Application and Specification
8.5.3 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Hospira(ICU Medical)
8.6.1 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.6.2 Hospira(ICU Medical) Product Introduction, Application and Specification
8.6.3 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Medtronic
8.7.1 Medtronic Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.7.2 Medtronic Product Introduction, Application and Specification
8.7.3 Medtronic Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Smiths Group
8.8.1 Smiths Group Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.8.2 Smiths Group Product Introduction, Application and Specification
8.8.3 Smiths Group Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Teleflex
8.9.1 Teleflex Intravenous (IV) Therapy and Vein Access Production Sites and Area Served
8.9.2 Teleflex Product Introduction, Application and Specification
8.9.3 Teleflex Intravenous (IV) Therapy and Vein Access Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Intravenous (IV) Therapy and Vein Access Market
9.1 Global Intravenous (IV) Therapy and Vein Access Market Trend Analysis
9.1.1 Global Intravenous (IV) Therapy and Vein Access Market Size (Volume and Value) Forecast 2019-2025
9.2 Intravenous (IV) Therapy and Vein Access Regional Market Trend
9.2.1 North America Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.2.2 Europe Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.2.3 China Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.2.4 Japan Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.2.5 Southeast Asia Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.2.6 India Intravenous (IV) Therapy and Vein Access Forecast 2019-2025
9.3 Intravenous (IV) Therapy and Vein Access Market Trend (Product Type)
9.4 Intravenous (IV) Therapy and Vein Access Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Intravenous (IV) Therapy and Vein Access Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

B. Braun、Baxter International、Becton Dickinson、C. R. Bard、Fresenius Kabi、Hospira(ICU Medical)、Medtronic、Smiths Group、Teleflex

★調査レポート[世界の静脈内(IV)療法及び静脈アクセス市場 2019年] (コード:QYR20FB03914)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の静脈内(IV)療法及び静脈アクセス市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆